Pathstone Family Office’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,200
| Closed | -$647K | – | 1219 |
|
|
2022
Q4 | $647K | Buy |
+5,200
| New | +$647K | 0.01% | 984 |
|
|
2021
Q1 | – | Sell |
-1,630
| Closed | -$133K | – | 696 |
|
|
2020
Q4 | $133K | Hold |
1,630
| – | – | 0.01% | 332 |
|
|
2020
Q3 | $116K | Buy |
1,630
+1,200
| +279% | +$85.4K | 0.01% | 260 |
|
|
2020
Q2 | $35K | Buy |
430
+205
| +91% | +$16.7K | ﹤0.01% | 359 |
|
|
2020
Q1 | $13K | Buy |
+225
| New | +$13K | ﹤0.01% | 478 |
|